Published on
April 18, 2023
- 20:30 GMT
BeyondSpring Provides Business Update and Reports Year End 2022 Financial Results
- SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration - BeyondSpring Completed Enrollment of Three Investigator-Initiated Trials (IIT) with Plinabulin in the U.S. for Multiple Cancer Indications NEW YORK, April …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
